This article was first published on FXTM Global.
This content is synced from the rightful owners. Copyright on text and images belong to the original source.
After yesterday’s selloff amid fresh daily record numbers of new Covid case in the US, stocks stateside have opened modestly higher while European bourses also trade mildly in the green. Pfizer announced that a final analysis of clinical trial data showed its Covid-19 vaccine was 95% effective, paving the way for the drugs giant to apply for the first US regulatory authorisation for a coronavirus shot within days.Although there has been a slight pullback after the news was announced, the reflation trade seems to be making a reappearance with the small cap Russell 2000 outperforming the... Read More
To keep reading this article, please navigate to: FXTM Global.